findmyKOL
Clinical trialNCT06492174Active, not recruitingPhase 3Interventional

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

SponsorBoston Scientific CorporationEnrollment20In-Stent Restenosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the AGENT IDE study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter in patients with in-stent restenosis (ISR) of a previously treated lesion of up to 36 mm in length (by visual estimate) in a native coronary artery 2.0 mm to 4.0 mm in diameter.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Carondelet Medical Group St. Mary'S Hospital

    Tucson, Arizona, United States

  • Cedars Sinai Medical Center

    Los Angeles, California, United States

  • Emory University Hospital

    Atlanta, Georgia, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • Columbia University Medical Center

    New York, New York, United States

  • St. Francis Hospital

    Roslyn, New York, United States

  • Lindner Center for Research and Education at Christ Hospital

    Cincinnati, Ohio, United States

  • Upmc Pinnacle Health

    Wormleysburg, Pennsylvania, United States

  • Rhode Island Hospital

    Providence, Rhode Island, United States

  • Centennial Medical Center

    Nashville, Tennessee, United States

  • Baylor Heart and Vascular Hospital

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Oct 2024
Primary completion
19 Dec 2025
Completion
31 Dec 2027
Last update posted
21 Aug 2026
Registered enrollment
20
Registry id
NCT06492174

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.